What You Need To Know About Patenting Chemical Inventions: Subject Matter Eligibility, Obviousness Requirement, and Regulatory Updates
Partner Shelley C. Danek Ph.D. and Associates Kimberly L. Berkowski, Ph.D. and Vivien C. Nielsen, Ph.D. will present, “Patenting Chemical Inventions” at the 2015 American Chemical Society National Meeting, beginning at 9:00 a.m. on March 25, 2015, at the Colorado Convention Center in Denver, CO.
- Dr. Danek will cover “Patent Eligible Subject Matter in the Chemical Arts,” an update on the recently issued guidelines that significantly restrict subject matter eligibility for chemical inventions, and provide strategies to navigate these new guidelines.
- Dr. Berkowski's talk, “Examination of the Obviousness Requirement for Patenting Chemical Compounds,” will provide an analysis of the obviousness requirement for patenting chemical compounds in view of recent Federal Circuit decisions.
- Dr. Nielsen's presentation “Getting From Bench-to-Bedside,” will look at how to successfully navigate the rules and regulations of agencies such as the FDA and EPA to deliver the chemical innovation to the market and those in need of these advancements.
Also presenting during this session:
- Jeffrey Hayes of The Procter and Gamble Company – “You Discovered Something New in the Lab…Now What?”
- Michael Carr of the University of Colorado Boulder – “Technology Transfer and Industry Collaborations: A New Era in Cooperative and Sponsored Research”
The American Chemical Society is the world's largest society for chemical professionals. This 249th ACS National Meeting and Exposition provides a chance to connect with thousands of chemical professionals wanting to explore the overarching multidisciplinary theme of Chemistry of Natural Resources. The five day meeting is packed with learning opportunities that will enrich your experience and cultivate new ideas and new contacts. For more information on the national meeting, click here.
About the speakers:
Shelley C. Danek, Ph.D. advances and secures the value of patents and intellectual property portfolios for clients developing pharmaceutical, biotech and nanotech products, including startup firms, international corporations and universities. Clients rely on Dr. Danek's understanding of their technologies and her assiduous attention to their businesses, qualities developed from her advanced study and research in chemistry and postdoctoral research in RNA interference.
Kimberly L. Berkowski, Ph.D. prosecutes patent applications in the chemical, pharmaceutical, and polymer/material sciences. Her technical research and teaching background enable her to work seamlessly with scientists and lay persons alike to produce quality work and favorable results. She has extensive bench experience with the synthesis, characterization, and application of small molecules, polymers, peptides, and biomaterials. Dr. Berkowski also brings exceptional technical communication skills that she cultivated during her years of teaching in academia.
Vivien C. Nielsen, Ph.D. assists in prosecuting patents in the pharmaceutical, chemical sciences and biotechnology industry areas. Dr. Nielsen also offers due diligence services related to patent strategy and assists with intellectual property litigation matters for clients.